Waste is our energy! Energy-from-Waste (EfW)
Hitachi Zosen acquires former Von Roll Inova to form Hitachi Zosen Inova AG
AE&E Inova Holding AG filed for bankruptcy on December 3, 2010, and Hitachi Zosen Corporation (日立造船株式会社) acquired 100% of the shares of AE&E Inova Holding AG in Zurich with approval of the bankruptcy court, and the acquisition became final on December 20, 2010.
Subsequently AE&E Inova Holding AG was renamed Hitachi Zosen Inova AG or abbreviated, HZI AG.
Hitachi Zosen Inova AG history
Inova was originally a department of the company “Gesellschaft der Ludwig von Roll’schen Eisenwerke” founded in 1823, the purpose was thermal waste treatment. Inova was founded in 1933 as “L. von Roll Bamag AG”.
In 1960, Von Roll expanded to Germany and Japan, and in 1966 to France and Sweden, and 1975 to USA. Von Roll Environmental Technology Ltd was known as “Von Roll Inova Group”.
In 2003, Von Roll Inova Group was acquired by the AE&E Group (Austrian Energy & Environment Group), a subsidiary representing about 40% of A-Tec Industries AG (http://www.atec-industries.com/). Both AE&E Group and A-Tec Industries AG went into bankruptcy proceedings. An overview of the complex bankruptcy and reconstruction proceedings can be found on the A-Tec Industries Wikipedia-page.
AE&E Inova Holding AG filed for bankruptcy on December 3, 2010, and was acquired by Hitachi Zosen Corporation as of December 20, 2010.
Read our report on Japan’s electronics industry and Hitachi:
Japan electronics industries – mono zukuri. Preview this report:
Register and receive an email with a link to a free trial version of our report on “Japan electronics industries” and our newsletters.
Copyright (c) 2014 Eurotechnology Japan KK All Rights Reserved
Boehringer Ingelheim acquisition values SSP at approx US$ 900 million
Boehringer Ingelheim acquires SSP stage-by-stage: 9.2% in 1996, 60% in 2001, 100% in 2010
Boehringer Ingelheim acquires SSP (エスエス製薬株式会社), a Japanese OTC pharma company founded originally in 1765 as a pharmacy in Yaesu, Tokyo, starting with business cooperation, followed by staged investment over a period of five years, starting in 1995, followed by a Take-Over-Bid and delisting of SSP from the Tokyo Stock Exchange in 2010.
SSP (エスエス製薬株式会社), founded in 1765
History, and acquisition steps by Boehringer Ingelheim:
- SSP (エスエス製薬株式会社) was founded in 1765 as a pharmacy in Yaesu, Tokyo
- On 29 October 1927 the company was incorporated as （株）瓢箪屋薬房
- In 1940 the company name was changed to (エスエス製薬株式会社)
- 1969 IPO on the 2nd section of the Tokyo Stock Exchange
- 1971 IPO on the 1st section of the Tokyo Stock Exchange
- 1995-1996 Boehringer Ingelheim invests in SSP, and becomes largest share holder
- 2001 Boehringer Ingelheim increases shareholding to above 50%
- 15 February 2010 Boehringer Ingelheim Japan Investment GK (ベーリンガーインゲルハイム・ジャパン・インベストメント合同会社) issues a Take-Over-Bid (TOB), which is concluded on 15 April 2010, resulting in Boehringer Ingelheim Investment Japan acquiring a total of 93% of SSP shares.
- 16 July 2010 SSP is delisted from Tokyo Stock Exchange
- 1 October 2010 merger with Boehringer Ingelheim Japan Investment GK (ベーリンガーインゲルハイム・ジャパン・インベストメント合同会社)
- 19 November 2010 merger with BI Nippon Invest GK (BIニッポンインベスト合同会社)
- 19 November 2010 becomes subsidiary of Boehringer Ingelheim Japan KK (ベーリンガーインゲルハイムジャパン株式会社)
- 1 January 2017 as part of a global asset swap of Boehringer Ingelheim with Sanofi, SSP becomes a subsidiary of the French pharmaceutical group Sanofi (サノフィ株式会社)
Nippon Boehringer Ingelheim Co., Ltd. (ベーリンガーインゲルハイム ジャパン株式会社)
Nippon Boehringer Ingelheim Co., Ltd. (ベーリンガーインゲルハイム ジャパン株式会社) was founded in 1961 as a subsidiary of the German Boehringer Ingelheim Group, which was founded in 1885 in Ingelheim am Rhein in 1885.
Copyright (c) 2010-2017 Eurotechnology Japan KK All Rights Reserved